TriSalus Life Sciences, Inc. (TLSI)
NASDAQ: TLSI · IEX Real-Time Price · USD
9.75
+0.31 (3.28%)
At close: Mar 28, 2024, 4:00 PM
9.54
-0.21 (-2.15%)
After-hours: Mar 28, 2024, 6:38 PM EDT

TriSalus Life Sciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 202220212020
Net Income
-47.19-28.85-0.71
Depreciation & Amortization
0.40.460
Share-Based Compensation
0.370.110
Other Operating Activities
14.115.580.03
Operating Cash Flow
-32.31-22.7-0.68
Capital Expenditures
-0.79-1.260
Acquisitions
-1-10
Change in Investments
00-250
Investing Cash Flow
-1.79-2.26-250
Share Issuance / Repurchase
0.090.05245.03
Debt Issued / Paid
-0.13-1.3-0.18
Other Financing Activities
13.552.027.17
Financing Cash Flow
13.4650.77252.01
Net Cash Flow
-20.6425.811.33
Free Cash Flow
-33.1-23.96-0.68
Free Cash Flow Margin
-266.97%-285.14%-
Free Cash Flow Per Share
-2.64-2.70-0.08
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).